Over $800 million in vaccines, medicines and health technology procured by PAHO’s Regional Revolving Funds in 2024
Oscar Reyes
24 Feb 2025
Oscar Reyes
24 Feb 2025
Oscar Reyes
21 Feb 2025
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-cerebrotendinous-xanthomatosis-rare-lipid-storage-disease
Oscar Reyes
21 Feb 2025
Oscar Reyes
14 Feb 2025
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
http://www.fda.gov/news-events/press-announcements/fda-approves-first-rapid-acting-insulin-biosimilar-product-treatment-diabetes
Cristina Mitchell
14 Feb 2025